Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
SkinBioTherapeutics PLC (GB:SBTX)
LSE:SBTX
Holding GB:SBTX?
Track your performance easily
SBTX Stock Chart & Stats
Day’s Range0p - 0p
52-Week Range7.00p - 29.50p
Previous Close10.5p
Volume9.49M
Average Volume (3M)1.24M
Market Cap
£23.74M
Enterprise Value22.53M
Total Cash (Recent Filing)£1.31M
Total Debt (Recent Filing)£100.65K
Price to Earnings (P/E)―
Beta0.34
Next Earnings
Nov 26, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding226,090,000
10 Day Avg. Volume1,549,186
30 Day Avg. Volume1,236,191
Standard Deviation0.34
R-Squared0.07
Alpha0.03
Financial Highlights & Ratios
Price to Book (P/B)525.00
Price to Sales (P/S)146.86
Price to Cash Flow (P/CF)-8.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
SkinBioTherapeutics News
PremiumCompany Announcements
SkinBioTherapeutics Gears Up for Market Launch
PremiumCompany Announcements
SkinBioTherapeutics Stakeholder Acquires More Shares
PremiumCompany Announcements
SkinBioTherapeutics Ownership Shift Noted
PremiumCompany Announcements
SkinBioTherapeutics Gains Strategic £1.56M Investment
PremiumCompany Announcements
SkinBioTherapeutics Gains Expertise with New AdvisorPremiumCompany Announcements
SkinBioTherapeutics Growth Surges Post-AcquisitionPremiumCompany Announcements
SkinBioTherapeutics Concludes Convertible Bond FacilityPremiumCompany Announcements
SkinBioTherapeutics Issues New Shares and Reduces BondsOptions Prices
Currently, No data available
---
Ownership Overview
0.54%
Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
99.46% Public Companies and
Individual Investors
SBTX FAQ
What was SkinBioTherapeutics PLC’s price range in the past 12 months?
SkinBioTherapeutics PLC lowest share price was 7.00p and its highest was 29.50p in the past 12 months.
What is SkinBioTherapeutics PLC’s market cap?
Currently, no data Available
When is SkinBioTherapeutics PLC’s upcoming earnings report date?
SkinBioTherapeutics PLC’s upcoming earnings report date is Nov 26, 2024 which is in 67 days.
How were SkinBioTherapeutics PLC’s earnings last quarter?
SkinBioTherapeutics PLC released its earnings results on Mar 22, 2024. The company reported -0.008p earnings per share for the quarter, missing the consensus estimate of N/A by -0.008p.
Is SkinBioTherapeutics PLC overvalued?
According to Wall Street analysts SkinBioTherapeutics PLC’s price is currently Overvalued.
Does SkinBioTherapeutics PLC pay dividends?
SkinBioTherapeutics PLC does not currently pay dividends.
What is SkinBioTherapeutics PLC’s EPS estimate?
SkinBioTherapeutics PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does SkinBioTherapeutics PLC have?
SkinBioTherapeutics PLC has 226,086,290 shares outstanding.
What happened to SkinBioTherapeutics PLC’s price movement after its last earnings report?
SkinBioTherapeutics PLC reported an EPS of -0.008p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 13.793%.
Which hedge fund is a major shareholder of SkinBioTherapeutics PLC?
Currently, no hedge funds are holding shares in GB:SBTX
---
SkinBioTherapeutics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
-53.33%
12-Months-Change
Fundamentals
Return on Equity
-118.64%
Trailing 12-Months
Asset Growth
111.81%
Trailing 12-Months
Company Description
SkinBioTherapeutics PLC
SkinBioTherapeutics PLC is a life science company focused on skin health. It is focused on the development of technology to protect, manage and restore skin utilizing proteins found in the human microbiota. SkinBioTherapeutics is targeting three specific skin healthcare sectors; cosmetics, infection control, and eczema. The company has one reportable segment namely the research and development of the SkinBiotix technology.
---
Technical Analysis
Futura Medical
―
Abingdon Health PLC
―
HemoGenyx Pharmaceuticals Plc
―
RUA Life Sciences
―
---